Lacunar Intervention Trial 1 (LACI-1) "Prevent-SVD"


Phase 2 Results N/A

Summary of Purpose

Phase II pilot randomised, factorial, short term dose escalation, open label, blinded intermediary endpoint trial, in two hospital centres in the UK, of tolerability and safety of cilostazol, isosorbide mononitrate, both or neither in patients with small vessel disease manifest as symptomatic small subcortical stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2016.

1 Oct 2015 19 Jun 2015 1 Jun 2017 1 Sep 2017 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment